Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications
Social media trend for weight loss puts strain on diabetes medication A viral weight loss trend is causing a shortage of a Type 2 diabetes drug
Wegovy is one of three semaglutide products
"We're here to customize personalized medicine so it results in a better treatment outcome compared to one size fits all approach that Big Pharma shoves down our throats," said Noorian, the CEO and founder of the Houston-based Empower Pharmacy, which he says is the largest dispenser of GLP-1 drugs other than Eli Lilly and Ozempic maker Novo Nordisk themselves
"These injections are often dispensed in vials, so theres a greater opportunity for dosing errors since youre measuring out your specific dose with a syringe," she warned
Safety remains our primary priority, so we establish clear safety netting regarding when to seek urgent medical help
US$ 21.03
US$ 29.48
US$ 27.21
US$ 25.71
US$ 26.38
US$ 22.86
US$ 20.98
US$ 21.75
US$ 29.29
